Cargando…
Characterization of the Protective Immune Responses Conferred by Recombinant BCG Overexpressing Components of Mycobacterium tuberculosis Sec Protein Export System
Mycobacterium bovis Bacillus Calmette-Guérin (BCG) is the only approved vaccine against tuberculosis (TB). However, its efficacy in preventing pulmonary TB in adults is limited. Despite its variable efficacy, BCG offers a number of unique and beneficial characteristics, which make it suitable as a v...
Autores principales: | Nisa, Annuurun, Counoupas, Claudio, Pinto, Rachel, Britton, Warwick J., Triccas, James A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229301/ https://www.ncbi.nlm.nih.gov/pubmed/35746553 http://dx.doi.org/10.3390/vaccines10060945 |
Ejemplares similares
-
Mycobacterium tuberculosis components expressed during chronic infection of the lung contribute to long-term control of pulmonary tuberculosis in mice
por: Counoupas, Claudio, et al.
Publicado: (2016) -
Delta inulin-based adjuvants promote the generation of polyfunctional CD4(+) T cell responses and protection against Mycobacterium tuberculosis infection
por: Counoupas, Claudio, et al.
Publicado: (2017) -
Boosting BCG with recombinant influenza A virus tuberculosis vaccines increases pulmonary T cell responses but not protection against Mycobacterium tuberculosis infection
por: Muflihah, Heni, et al.
Publicado: (2021) -
L-selectin-dependent and -independent homing of naïve lymphocytes through the lung draining lymph node support T cell response to pulmonary Mycobacterium tuberculosis infection
por: Daniel, Lina, et al.
Publicado: (2023) -
Stromal structure remodeling by B lymphocytes limits T cell activation in lymph nodes of Mycobacterium tuberculosis–infected mice
por: Daniel, Lina, et al.
Publicado: (2022)